EUVIMEDEUVIMED entdecken
Crossref

Polymorphisms of FGFR Pathway-related Factors and Capecitabine-induced Hand-foot Syndrome in Japanese Patients With Colorectal Cancer

Riku Yamanaka, Natsumi Matsumoto, Remi Murase, Yutaro Kubota, Hiroo Ishida, Ken Shimada, Ken-Ichi Fujita

Anticancer Research · 2026

DOI: 10.21873/anticanres.17991 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2026. Verfasst von Riku Yamanaka und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Genome and Pharmacotherapy, Showa Medical University Graduate School of Pharmacy, Tokyo, Japan. Hauptthemen laut MEDLINE: Antimetabolites, Antineoplastic, Capecitabine, Colorectal Neoplasms, Hand-Foot Syndrome.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antimetabolites, AntineoplasticCapecitabineColorectal NeoplasmsHand-Foot SyndromePolymorphism, Single NucleotideReceptor, Fibroblast Growth Factor, Type 2AdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedJapanRetrospective StudiesSignal TransductionEast Asian People

Stichwörter der Autor:innen

CapecitabineFGFBP2FGFR signaling pathwayFGFR2SPRY2hand-foot syndrome

Substanzen

Antimetabolites, AntineoplasticCapecitabineFGFR2 protein, humanReceptor, Fibroblast Growth Factor, Type 2

Autor:innen und Institutionen

  • Department of Cancer Genome and Pharmacotherapy, Showa Medical University Graduate School of Pharmacy, Tokyo, Japan.
  • Division of Cancer Genome and Pharmacotherapy, Department of Clinical Pharmacy, Showa Medical University School of Pharmacy, Tokyo, Japan.
  • Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan.
  • Division of Medical Oncology, Showa Medical University Fujigaoka Hospital, Yokohama, Japan.
  • Division of Medical Oncology, Showa Medical University Koto Toyosu Hospital, Tokyo, Japan.
  • Department of Cancer Genome and Pharmacotherapy, Showa Medical University Graduate School of Pharmacy, Tokyo, Japan; k.fujita@med.showa-u.ac.jp.

Zitieren

APA

Yamanaka, R., Matsumoto, N., Murase, R., Kubota, Y., Ishida, H., Shimada, K., & Fujita, K. I. (2026). Polymorphisms of FGFR Pathway-related Factors and Capecitabine-induced Hand-foot Syndrome in Japanese Patients With Colorectal Cancer. Anticancer Research. https://doi.org/10.21873/anticanres.17991

Vancouver

Yamanaka R, Matsumoto N, Murase R, Kubota Y, Ishida H, Shimada K, et al. Polymorphisms of FGFR Pathway-related Factors and Capecitabine-induced Hand-foot Syndrome in Japanese Patients With Colorectal Cancer. Anticancer Research. 2026. doi:10.21873/anticanres.17991

BibTeX
@article{Yamanaka2026,
  author = {Yamanaka, Riku and Matsumoto, Natsumi and Murase, Remi and Kubota, Yutaro and Ishida, Hiroo and Shimada, Ken and Fujita, Ken-Ichi},
  title = {Polymorphisms of FGFR Pathway-related Factors and Capecitabine-induced Hand-foot Syndrome in Japanese Patients With Colorectal Cancer},
  journal = {Anticancer Research},
  year = {2026},
  doi = {10.21873/anticanres.17991}
}
Kostenlos starten →